MANNKIND CORP Repayments of Senior Debt
MANNKIND CORP (MNKD) reported Repayments of Senior Debt of $64.29 million for the 12-month period ending 2015-12-31, per its 10-K filed 2018-02-27.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfSeniorDebt · last filed 2018-02-27
- MANNKIND CORP repayments of senior debt for the quarter ending 2015-12-31 was $0.00.
- MANNKIND CORP repayments of senior debt for fiscal 2015 was $64.29M.
- MANNKIND CORP repayments of senior debt for fiscal 2013 was $115.00M.
| Period end | Repayments of Senior Debt 0 month | Repayments of Senior Debt 3 month | Repayments of Senior Debt 9 month | Repayments of Senior Debt 12 month | Repayments of Senior Debt 275 month | Repayments of Senior Debt 277 month | Repayments of Senior Debt 280 month | Repayments of Senior Debt 283 month |
|---|---|---|---|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $64.29M 10-K · filed 2018-02-27 | ||||||
| 2015-09-30 | $64.29M 10-Q · filed 2016-11-09 | |||||||
| 2014-09-30 | $115.00M 10-Q · filed 2014-11-10 | |||||||
| 2014-06-30 | $115.00M 10-Q · filed 2014-08-11 | |||||||
| 2014-03-31 | $115.00M 10-Q · filed 2014-05-12 | |||||||
| 2013-12-31 | $115.00M 10-K · filed 2015-03-02 | $115.00M 10-K · filed 2014-03-03 | ||||||
| 2013-12-15 | $115.00M 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |